FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
4,307 products (finished products)
| Product | Strength | Form · route | Labeler | Application | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|---|
| Heparin Sodium | Heparin sodium 1000 [USP'U]/mL | Injection, SolutionIntravenous, Subcutaneous | Hepalink USA Inc. | ANDA | 81952-112 | 81952-0112-0681952-0112-0981952-0112-10 | — |
| Heparin Sodium | Heparin sodium 10000 [USP'U]/mL | Injection, SolutionIntravenous, Subcutaneous | Hepalink USA Inc. | ANDA | 81952-113 | 81952-0113-0681952-0113-08 | — |
| Heparin Sodium | Heparin sodium 5000 [USP'U]/mL | Injection, SolutionIntravenous, Subcutaneous | Hepalink USA Inc. | ANDA | 81952-114 | 81952-0114-09 | — |
| Heparin Sodium | Heparin sodium 1000 [USP'U]/mL | Injection, Solution |
| Hepalink USA Inc. |
| ANDA |
| 81952-115 |
| 81952-0115-07 |
| — |
| Heparin Sodium | Heparin sodium 20000 [USP'U]/mL | Injection, SolutionIntravenous, Subcutaneous | Hepalink USA Inc. | ANDA | 81952-116 | 81952-0116-06 | — |
|---|
| Heparin Sodium | Heparin sodium 5000 [USP'U]/mL | InjectionIntravenous, Subcutaneous | Plano Pharmaceuticals Inc. | ANDA | 87188-102 | 87188-0102-90 | — |
|---|
| Heparin Sodium and Dextroseheparin sodium | Heparin sodium 10000 [USP'U]/100mL | Injection, SolutionIntravenous | Hospira, Inc. | NDA | 0409-4520 | 00409-4520-30 | — |
|---|
| Heparin Sodium in Dextroseheparin sodium and dextrose | Heparin sodium 4000 [USP'U]/100mL; Dextrose monohydrate 5 g/100mL | InjectionIntravenous | B. Braun Medical Inc. | NDA | 0264-9567 | 00264-9567-10 | — |
|---|
| Heparin Sodium in Dextroseheparin sodium and dextrose | Heparin sodium 5000 [USP'U]/100mL; Dextrose monohydrate 5 g/100mL | InjectionIntravenous | B. Braun Medical Inc. | NDA | 0264-9577 | 00264-9577-10 | — |
|---|
| Heparin Sodium in Dextroseheparin sodium and dextrose | Heparin sodium 10000 [USP'U]/100mL; Dextrose monohydrate 5 g/100mL | InjectionIntravenous | B. Braun Medical Inc. | NDA | 0264-9587 | 00264-9587-20 | — |
|---|
| Heparin Sodium in Sodium Chloride | Heparin sodium 5000 [USP'U]/100mL | InjectionIntravenous | B. Braun Medical Inc. | NDA | 0264-3301 | 00264-3301-10 | — |
|---|
| Heparin Sodium in Sodium Chloride | Heparin sodium 10000 [USP'U]/100mL | InjectionIntravenous | B. Braun Medical Inc. | NDA | 0264-3462 | 00264-3462-20 | — |
|---|
| Heparin Sodium in Sodium Chloride | Heparin sodium 200 [USP'U]/100mL | InjectionIntravenous | B. Braun Medical Inc. | NDA | 0264-9872 | 00264-9872-0000264-9872-10 | — |
|---|
| Heparin Sodium In Sodium Chlorideheparin sodium | Heparin sodium 200 [USP'U]/100mL | Injection, SolutionIntravenous | Baxter Healthcare Corporation | NDA | 0338-0424 | 00338-0424-18 | — |
|---|
| Heparin Sodium In Sodium Chlorideheparin sodium | Heparin sodium 200 [USP'U]/100mL | Injection, SolutionIntravenous | Baxter Healthcare Corporation | NDA | 0338-0428 | 00338-0428-12 | — |
|---|
| Heparin Sodium In Sodium Chlorideheparin sodium | Heparin sodium 200 [USP'U]/100mL | Injection, SolutionIntravenous | Baxter Healthcare Corporation | NDA | 0338-0431 | 00338-0431-03 | — |
|---|
| Heparin Sodium In Sodium Chlorideheparin sodium | Heparin sodium 200 [USP'U]/100mL | Injection, SolutionIntravenous | Baxter Healthcare Corporation | NDA | 0338-0433 | 00338-0433-04 | — |
|---|
| Heparin Sodium In Sodium Chloride | Heparin sodium 10000 [USP'U]/100mL | Injection, SolutionIntravenous | HF Acquisition Co LLC, DBA HealthFirst | NDA | 51662-1578 | 51662-1578-01 | — |
|---|
| Hepastatbeta vulgaris, carduus marianus, taraxacum officinale, cholesterinum, fel tauri, chelidonium majus, lycopodium clavatum, natrum sulphuricum, nux vomica, phosphorus | Beta vulgaris whole 3 [hp_X]/mL + 9 more ingredients | LiquidOral | Energique, Inc. | Unapproved homeopathic | 44911-0070 | 44911-0070-01 | — |
|---|
| Hepastatbeta vulgaris, carduus marianus, taraxacum officinale, cholesterinum, cholinum, fel tauri, calcarea carbonica, chelidonium majus, lycopodium clavatum, mercurius solubilis, natrum sulphuricum, nux vomica, phosphorus | Beta vulgaris whole 3 [hp_X]/mL + 12 more ingredients | LiquidOral | Energique, Inc. | Unapproved homeopathic | 44911-0739 | 44911-0739-01 | — |
|---|
| Hepataforcecarduus marianus, chelidonium majus, taraxacum officinale, lycopodium clavatum, magnesia phosphorica, natrum sulphuricum | Milk thistle 3 [hp_X]/mL + 5 more ingredients | LiquidOral | BioActive Nutritional | Unapproved homeopathic | 43857-0231 | 43857-0231-01 | — |
|---|
| Hepataplexboldo, carduus marianus, chelidonium majus, lappa major, petroselinum sativum, taraxacum officinale, glutathione, hepar suis, lycopodium clavatum, nux vomica, phosphorus | Peumus boldus leaf 3 [hp_X]/mL + 10 more ingredients | LiquidOral | BioActive Nutritional, Inc. | Unapproved homeopathic | 43857-0627 | 43857-0627-01 | — |
|---|
| Hepatatoxtriticum aestivum, chelidonium majus, taraxacum officinale, glutathione, hepar suis, thyroidinum (suis), lycopodium clavatum, nux vomica, phosphoricum acidum, adrenocorticotrophin, salicylicum acidum, cortisone aceticum, eugenol, stearyl alcohol, xylitol, folliculinum, benzoicum acidum, chlorinum potassium sorbate, sorbitol, resorcinum, benzyl alcohol, lacticum acidum, isopropyl palmitate, boricum acidum, aceticum acidum, phenyl butazone, petroleum jelly, plumbum metallicum | Triticum aestivum whole 1 [hp_X]/mL + 28 more ingredients | LiquidOral | BioActive Nutritional, Inc | Unapproved homeopathic | 43857-0543 | 43857-0543-01 | — |
|---|
| Hepatic-Tonecarduus marianus, ceanothus americanus, chelidonium majus, chionanthus virginica, citricum acidum, cysteinum, hepar suis, leptandra virginica, magnesia muriatica, natrum sulphuricum, nux vomica, phosphorus, quassia (amara), taraxacum officinale | Milk thistle 4 [hp_X]/mL + 13 more ingredients | LiquidOral | Energetix Corporation | Unapproved homeopathic | 64578-0085 | 64578-0085-01 | — |
|---|
| Hepatica Trilobaanemone hepatica var obtusa | Anemone hepatica var. Obtusa 30 [hp_C]/30[hp_C] | PelletOral | Boiron | Unapproved homeopathic | 0220-2478 | 00220-2478-41 | — |
|---|
| Hepaticol Drops 5008hepaticol drops | Milk thistle 2 [hp_X]/59mL + 13 more ingredients | LiquidOral | Professional Complementary Health Formulas | Unapproved homeopathic | 63083-5008 | 63083-5008-02 | — |
|---|
| Hepaticol Sarcodecarduus marianus, zingiber officinale, berberis vulgaris, chelidonium majus, magnesia muriatica, leptandra virginica, natrum muriaticum, bryonia (alba), hepar (bovine), natrum sulphuricum, atropinum sulphuricum, lycopodium clavatum | Milk thistle 3 [hp_X]/mL + 11 more ingredients | SprayOral | Nutritional Specialties, Inc. | Unapproved homeopathic | 83027-0098 | 83027-0098-01 | — |
|---|
| Hepatitis C Nosode 4447hepatitis c nosode | Hepatitis c immune globulin (Human) 30 [hp_X]/59mL | LiquidOral | Professional Complementary Health Formulas | Unapproved homeopathic | 63083-4447 | 63083-4447-02 | — |
|---|
| Hepatitis Nosode 4006hepatitis nosode | Hepatitis a virus strain hm175 antigen (Formaldehyde inactivated) 30 [hp_X]/59mL + 2 more ingredients | LiquidOral | Professional Complementary Health Formulas | Unapproved homeopathic | 63083-4006 | 63083-4006-02 | — |
|---|
| Hepatonecarduus marianus, chelidonium majus, taraxacum officinale, lycopodium clavatum, natrum sulphuricum, nux vomica, phosphorus | Milk thistle 3 [hp_X]/mL + 6 more ingredients | LiquidOral | Energique, Inc. | Unapproved homeopathic | 44911-0259 | 44911-0259-01 | — |
|---|
| Hepcludexbulevirtide | Bulevirtide acetate 8.5 mg/1 | Injection, Powder, Lyophilized, For solutionSubcutaneous | Gilead Sciences, Inc. | BLA | 61958-3104 | 61958-3104-01 | — |
|---|
| Heplisav-Bhepatitis b vaccine (recombinant) adjuvanted | Hepatitis b virus subtype adw hbsag surface protein antigen 20 ug/.5mL | Injection, SolutionIntramuscular | Dynavax Technologies Corporation | BLA | 43528-003 | 43528-0003-05 | — |
|---|
| Heplisav-Bhepatitis b vaccine (recombinant) adjuvanted | Hepatitis b virus subtype adw hbsag surface protein antigen 20 ug/.5mL | Injection, SolutionIntramuscular | A-S Medication Solutions | BLA | 50090-4526 | 50090-4526-00 | — |
|---|
| Heplisav-Bhepatitis b vaccine (recombinant) adjuvanted | Hepatitis b virus subtype adw hbsag surface protein antigen 20 ug/.5mL | Injection, SolutionIntramuscular | Bamboo US BidCo LLC | BLA | 83703-048 | 83703-0048-05 | — |
|---|
| Hepzato Kitmelphalan hydrochloride injection, powder, lyophilized, for solution | — | KitIntra-arterial | Delcath Systems, Inc. | NDA | 75833-601 | 75833-0601-0175833-0601-0275833-0601-07+1 more | — |
|---|
| Her Stylelevonorgestrel | Levonorgestrel 1.5 mg/1 | TabletOral | Ingenus Pharmaceuticals, LLC | ANDA | 50742-352 | 50742-0352-01 | — |
|---|
| Hera Black Cushion Foundation 13N1octinoxate, titanium dioxide, and zinc oxide | Octinoxate .9743 g/15g + 2 more ingredients | LotionTopical | Amorepacific Corporation | OTC monograph drug | 43419-240 | 43419-0240-31 | — |
|---|
| Hera Black Cushion Foundation 17C2octinoxate, titanium dioxide, and zinc oxide | Octinoxate .9743 g/15g + 2 more ingredients | LotionTopical | Amorepacific Corporation | OTC monograph drug | 43419-241 | 43419-0241-31 | — |
|---|
| Hera Black Cushion Foundation 17N1octinoxate, titanium dioxide, and zinc oxide | Octinoxate .9743 g/15g + 2 more ingredients | LotionTopical | Amorepacific Corporation | OTC monograph drug | 43419-242 | 43419-0242-31 | — |
|---|
| Hera Black Cushion Foundation 19N1octinoxate, titanium dioxide, and zinc oxide | Octinoxate .9743 g/15g + 2 more ingredients | LotionTopical | Amorepacific Corporation | OTC monograph drug | 43419-243 | 43419-0243-31 | — |
|---|
| Hera Black Cushion Foundation 21C2octinoxate, titanium dioxide, and zinc oxide | Octinoxate .9743 g/15g + 2 more ingredients | LotionTopical | Amorepacific Corporation | OTC monograph drug | 43419-244 | 43419-0244-31 | — |
|---|
| Hera Black Cushion Foundation 21N1octinoxate, titanium dioxide, and zinc oxide | Octinoxate .9743 g/15g + 2 more ingredients | LotionTopical | Amorepacific Corporation | OTC monograph drug | 43419-245 | 43419-0245-31 | — |
|---|
| Hera Black Cushion Foundation 21W1octinoxate, titanium dioxide, and zinc oxide | Octinoxate .9743 g/15g + 2 more ingredients | LotionTopical | Amorepacific Corporation | OTC monograph drug | 43419-246 | 43419-0246-31 | — |
|---|
| Hera Black Cushion Foundation 22N1octinoxate, titanium dioxide, and zinc oxide | Octinoxate .9743 g/15g + 2 more ingredients | LotionTopical | Amorepacific Corporation | OTC monograph drug | 43419-247 | 43419-0247-31 | — |
|---|
| Hera Black Cushion Foundation 22N1octinoxate, titanium dioxide, and zinc oxide | Octinoxate .9743 g/15g + 2 more ingredients | LotionTopical | Amorepacific Corporation | OTC monograph drug | 43419-248 | 43419-0248-31 | — |
|---|
| Hera Black Cushion Foundation 22N1octinoxate, titanium dioxide, and zinc oxide | Octinoxate .9743 g/15g + 2 more ingredients | LotionTopical | Amorepacific Corporation | OTC monograph drug | 43419-249 | 43419-0249-31 | — |
|---|
| Hera Black Cushion Foundation 26N1octinoxate, titanium dioxide, and zinc oxide | Octinoxate .9743 g/15g + 2 more ingredients | LotionTopical | Amorepacific Corporation | OTC monograph drug | 43419-250 | 43419-0250-31 | — |
|---|
| Hera Black Cushion Foundation 26W1octinoxate, titanium dioxide, and zinc oxide | Octinoxate .9743 g/15g + 2 more ingredients | LotionTopical | Amorepacific Corporation | OTC monograph drug | 43419-251 | 43419-0251-31 | — |
|---|
| Hera Black Cushion Foundation 28C1octinoxate, titanium dioxide, and zinc oxide | Octinoxate .9743 g/15g + 2 more ingredients | LotionTopical | Amorepacific Corporation | OTC monograph drug | 43419-260 | 43419-0260-31 | — |
|---|
| Hera Black Cushion Foundation 28N1octinoxate | Octinoxate .9743 g/15g | LotionTopical | Amorepacific Corporation | OTC monograph drug | 43419-261 | 43419-0261-31 | — |
|---|